glutathione kills triple negative cancer responsive nanomedicine leverages tumor redox imbalance for targeted theranostics | Discover Oncology GPX4 in triple-negative breast cancer:
GPX4 in triple negative breast cancer: A key regulator of ferroptosis and therapeutic target ScienceDirect A photodynamic mediated glutamine metabolic intervention nanodrug for triple negative breast cancer therapy ScienceDirect Tumor targeted glutathione oxidation catalysis with ruthenium nanoreactors against hypoxic osteosarcoma Nature Communications Glutathione Dependent Pathways in Cancer Cells Glutathione in Cancer Cell Death
Pay in 4 interest-free payments of $7.32 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9




